BRPI0407901A - diarylcycloalkyl derivatives, processes for their preparation and use as medicines - Google Patents
diarylcycloalkyl derivatives, processes for their preparation and use as medicinesInfo
- Publication number
- BRPI0407901A BRPI0407901A BRPI0407901-9A BRPI0407901A BRPI0407901A BR PI0407901 A BRPI0407901 A BR PI0407901A BR PI0407901 A BRPI0407901 A BR PI0407901A BR PI0407901 A BRPI0407901 A BR PI0407901A
- Authority
- BR
- Brazil
- Prior art keywords
- derivatives
- processes
- disorders
- medicines
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
"DERIVADOS DE DIARILCICLOALQUILA, PROCESSOS PARA PREPARAçãO DOS MESMOS E USO DOS MESMOS COMO MEDICAMENTOS". A invenção refere-se a derivados de diarilcicloalquila, a seus sais fisiologicamente compatíveis, racematos e derivados fisiologicamente funcionais. A invenção refere-se a compostos da fórmula (I), nos quais os grupos estão definidos tal como citado na descrição, além de seus sais fisiologicamente compatíveis e a um método para a produção dos mesmos. Os compostos são apropriados para tratamento e/ou prevenção de distúrbios do metabolismo de ácidos graxos e distúrbios de utilização de glicose, além de distúrbios, nos quais a resistência à insulina desempenha um papel."DIARYLYCYCLALCHILLA DERIVATIVES, PROCESSES FOR PREPARING THEMSELVES AND USING THEMSELVES AS MEDICINAL PRODUCTS". The invention relates to diarylcycloalkyl derivatives, their physiologically compatible salts, racemates and physiologically functional derivatives. The invention relates to compounds of formula (I) wherein the groups are as defined in the description, in addition to their physiologically compatible salts and a method for their production. The compounds are suitable for treating and / or preventing fatty acid metabolism disorders and glucose utilization disorders, as well as disorders in which insulin resistance plays a role.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10308353A DE10308353A1 (en) | 2003-02-27 | 2003-02-27 | Diarylcycloalkyl derivatives, processes for their preparation and their use as medicines |
PCT/EP2004/001584 WO2004075815A2 (en) | 2003-02-27 | 2004-02-19 | Diarylcycloalkyl derivatives, method for their production and their use as medicaments |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0407901A true BRPI0407901A (en) | 2006-02-14 |
Family
ID=32920627
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0407901-9A BRPI0407901A (en) | 2003-02-27 | 2004-02-19 | diarylcycloalkyl derivatives, processes for their preparation and use as medicines |
Country Status (21)
Country | Link |
---|---|
US (1) | US7160911B2 (en) |
EP (1) | EP1599454B1 (en) |
JP (1) | JP2006519197A (en) |
KR (1) | KR20050106053A (en) |
CN (1) | CN100439346C (en) |
AR (1) | AR043430A1 (en) |
AU (1) | AU2004216520B2 (en) |
BR (1) | BRPI0407901A (en) |
CA (1) | CA2516573A1 (en) |
CO (1) | CO5690579A2 (en) |
DE (1) | DE10308353A1 (en) |
HR (1) | HRP20050740A2 (en) |
IL (1) | IL170313A (en) |
MA (1) | MA27741A1 (en) |
MX (1) | MXPA05008993A (en) |
NO (1) | NO20054382L (en) |
PL (1) | PL377741A1 (en) |
RU (1) | RU2005129999A (en) |
TW (1) | TW200505880A (en) |
WO (1) | WO2004075815A2 (en) |
ZA (1) | ZA200505763B (en) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7399777B2 (en) * | 2001-08-31 | 2008-07-15 | Sanofi-Aventis Deutschland Gmbh | Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmceuticals |
ES2278077T3 (en) * | 2001-08-31 | 2007-08-01 | Sanofi-Aventis Deutschland Gmbh | DERIVATIVES OF DIARILCICLOALQUILO, PROCEDURE FOR ITS PREPARATION AND ITS USE AS PPAR ACTIVATORS. |
NZ552501A (en) | 2004-08-11 | 2010-03-26 | Kyorin Seiyaku Kk | Novel cyclic aminobenzoic acid derivative |
DE102004040736B4 (en) * | 2004-08-23 | 2007-01-11 | Sanofi-Aventis Deutschland Gmbh | Process for the preparation of Diarylcycloalkylderivaten |
DE102004060227B3 (en) * | 2004-12-15 | 2006-07-20 | Sanofi-Aventis Deutschland Gmbh | Process for the preparation of oxazoles by condensation of aromatic aldehydes with α-ketoximes to N-oxides and subsequent reaction with activated acid derivatives |
US20090036489A1 (en) * | 2005-03-22 | 2009-02-05 | Masahiro Nomura | Novel Cyclic Aminophenylalkanoic Acid Derivative |
ZA200802857B (en) | 2005-09-14 | 2009-09-30 | Takeda Pharmaceutical | Dipeptidyl peptidase inhibitors for treating diabetes |
KR101368988B1 (en) | 2005-09-16 | 2014-02-28 | 다케다 야쿠힌 고교 가부시키가이샤 | Dipeptidyl peptidase inhibitors |
CN101272784A (en) | 2005-09-29 | 2008-09-24 | 塞诺菲-安万特股份有限公司 | Phenyl- and pyridinyl- 1, 2 , 4 - oxadiazolone derivatives, processes for their preparation and their use as pharmaceuticals |
WO2007112347A1 (en) | 2006-03-28 | 2007-10-04 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US8324383B2 (en) | 2006-09-13 | 2012-12-04 | Takeda Pharmaceutical Company Limited | Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile |
TW200838536A (en) | 2006-11-29 | 2008-10-01 | Takeda Pharmaceutical | Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor |
US8093236B2 (en) | 2007-03-13 | 2012-01-10 | Takeda Pharmaceuticals Company Limited | Weekly administration of dipeptidyl peptidase inhibitors |
US8153644B2 (en) * | 2007-05-22 | 2012-04-10 | Madrigal Pharmaceuticals, Inc. | Diacylglycerol acyltransferase inhibitors |
US8115011B2 (en) * | 2007-05-22 | 2012-02-14 | Madrigal Pharmaceuticals, Inc. | Diacylglycerol acyltransferase inhibitors |
US8211884B2 (en) * | 2008-08-06 | 2012-07-03 | Madrigal Pharmaceuticals, Inc. | Diacylglycerol acyltransferase inhibitors |
US8324385B2 (en) * | 2008-10-30 | 2012-12-04 | Madrigal Pharmaceuticals, Inc. | Diacylglycerol acyltransferase inhibitors |
CA2745445A1 (en) * | 2008-12-17 | 2010-07-08 | Via Pharmaceuticals, Inc. | Inhibitors of diacylglycerol aclytransferase |
Family Cites Families (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2663336B1 (en) | 1990-06-18 | 1992-09-04 | Adir | NOVEL PEPTIDE DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME. |
AU658955B2 (en) * | 1992-01-28 | 1995-05-04 | Sumitomo Chemical Company, Limited | An oxazoline derivative, its production and its use |
ZA941003B (en) | 1993-02-15 | 1995-08-14 | Wellcome Found | Hypolipidaemic compounds |
IL108634A0 (en) | 1993-02-15 | 1994-05-30 | Wellcome Found | Hypolipidaemic heterocyclic compounds, their prepatation and pharmaceutical compositions containing them |
JP3144624B2 (en) | 1995-06-02 | 2001-03-12 | 杏林製薬株式会社 | N-benzyldioxothiazolidylbenzamide derivative and method for producing the same |
HUP9902056A3 (en) | 1996-01-17 | 2002-02-28 | Novo Nordisk As | Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use |
PL192359B1 (en) | 1996-08-30 | 2006-10-31 | Novo Nordisk As | Glp-1 derivatives |
TW492957B (en) | 1996-11-07 | 2002-07-01 | Novartis Ag | N-substituted 2-cyanopyrrolidnes |
DK0958296T3 (en) | 1996-12-31 | 2003-08-18 | Reddys Lab Ltd Dr | Heterocyclic Compounds, Methods of Preparation and Pharmaceutical Preparations Containing Them and Their Use in the Treatment of Diabetes and Related Diseases |
AUPO713297A0 (en) * | 1997-06-02 | 1997-06-26 | Fujisawa Pharmaceutical Co., Ltd. | Oxazole compound |
DE19726167B4 (en) | 1997-06-20 | 2008-01-24 | Sanofi-Aventis Deutschland Gmbh | Insulin, process for its preparation and pharmaceutical preparation containing it |
EP1000066A1 (en) | 1997-07-16 | 2000-05-17 | Novo Nordisk A/S | Fused 1,2,4-thiadiazine derivatives, their preparation and use |
CO4970713A1 (en) | 1997-09-19 | 2000-11-07 | Sanofi Synthelabo | DERIVATIVES OF CARBOXAMIDOTIAZOLES, THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM |
JP4345230B2 (en) * | 1998-03-10 | 2009-10-14 | 小野薬品工業株式会社 | Carboxylic acid derivatives and drugs containing the derivatives as active ingredients |
DE19823831A1 (en) | 1998-05-28 | 1999-12-02 | Probiodrug Ges Fuer Arzneim | New pharmaceutical use of isoleucyl thiazolidide and its salts |
MA26634A1 (en) | 1998-06-04 | 2004-12-20 | Astra Ab | NOVEL 3-ARYL PROPIONIC ACID DERIVATIVES AND THE LIKE |
SE9801992D0 (en) | 1998-06-04 | 1998-06-04 | Astra Ab | New 3-aryl-2-hydroxypropionic acid derivative I |
US6221897B1 (en) | 1998-06-10 | 2001-04-24 | Aventis Pharma Deutschland Gmbh | Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use |
DE19828113A1 (en) | 1998-06-24 | 2000-01-05 | Probiodrug Ges Fuer Arzneim | Prodrugs of Dipeptidyl Peptidase IV Inhibitors |
DE19828114A1 (en) | 1998-06-24 | 2000-01-27 | Probiodrug Ges Fuer Arzneim | Produgs of unstable inhibitors of dipeptidyl peptidase IV |
WO2000001679A1 (en) * | 1998-07-01 | 2000-01-13 | Takeda Chemical Industries, Ltd. | Retinoid-associated receptor regulators |
DE19845405C2 (en) | 1998-10-02 | 2000-07-13 | Aventis Pharma Gmbh | Aryl-substituted propanolamine derivatives and their use |
US6589969B1 (en) * | 1998-10-16 | 2003-07-08 | Ono Pharmaceutical Co., Ltd. | Carboxylic acid derivatives and drugs containing the same as the active ingredient |
GB9900416D0 (en) | 1999-01-08 | 1999-02-24 | Alizyme Therapeutics Ltd | Inhibitors |
DE19916108C1 (en) | 1999-04-09 | 2001-01-11 | Aventis Pharma Gmbh | 1,4-Benzothiazepine-1,1-dioxide derivatives substituted with sugar residues, process for their preparation and their use |
EP1173438A1 (en) | 1999-04-16 | 2002-01-23 | Novo Nordisk A/S | Substituted imidazoles, their preparation and use |
BR0010126A (en) * | 1999-04-28 | 2002-02-26 | Aventis Pharma Gmbh | Tri-aryl acid derivatives as ppar receptor ligands |
ATE368037T1 (en) | 1999-04-28 | 2007-08-15 | Sanofi Aventis Deutschland | DI-ARYL ACID DERIVATIVES AS PPAR RECEPTOR LIGANDS |
WO2000066585A1 (en) | 1999-04-30 | 2000-11-09 | Neurogen Corporation | 9H-PYRIMIDO[4,5-b]INDOLE DERIVATIVES: CRF1 SPECIFIC LIGANDS |
GB9911863D0 (en) | 1999-05-21 | 1999-07-21 | Knoll Ag | Therapeutic agents |
CA2376919C (en) | 1999-06-18 | 2008-11-04 | Merck & Co., Inc. | Arylthiazolidinedione and aryloxazolidinedione derivatives |
US6413737B1 (en) | 1999-07-09 | 2002-07-02 | Cohesion Technologies, Inc. | Ecarin prothrombin protease and methods |
ES2203498T3 (en) | 1999-07-29 | 2004-04-16 | Eli Lilly And Company | BENZOFURILPIPERAZINAS: SEROTONINE 5-HT2C RECEPTOR AGONISTS. |
RU2002107998A (en) | 1999-09-01 | 2003-11-10 | АВЕНТИС ФАРМА ДОЙЧЛАНД ГмбХ (DE) | SULPHYL NARCARBOXAMIDE DERIVATIVES, METHOD FOR PRODUCING THEM AND THEIR USE AS MEDICINES |
AU7115300A (en) * | 1999-09-08 | 2001-04-10 | Glaxo Group Limited | Oxazole ppar antagonists |
US6414002B1 (en) * | 1999-09-22 | 2002-07-02 | Bristol-Myers Squibb Company | Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
TW200514783A (en) | 1999-09-22 | 2005-05-01 | Bristol Myers Squibb Co | Substituted acid derivatives useful as antiodiabetic and antiobesity agents and method |
WO2001040171A1 (en) | 1999-12-03 | 2001-06-07 | Astrazeneca Ab | Crystalline form of (s)-2 ethoxy-3-[4-(2-{4-methanesulfonyloxyphenyl} ethoxy) phenyl] propanoic acid |
SE9904413D0 (en) | 1999-12-03 | 1999-12-03 | Astra Ab | Comminuted form |
DK2055302T3 (en) | 2000-03-31 | 2014-10-27 | Royalty Pharma Collection Trust | PROCEDURE FOR IMPROVING ISLAND CELL SIGNALS BY DIABETES MELLITUS AND PREVENTION thereof |
EE200200601A (en) | 2000-04-25 | 2004-04-15 | Kyorin Pharmaceutical Co., Ltd. | A novel stable crystalline and thiazolidinedione derivative process for its preparation |
AU5257401A (en) | 2000-04-28 | 2001-11-12 | Asahi Chemical Ind | Novel bicyclic compounds |
DE60115227T2 (en) | 2000-05-11 | 2006-08-24 | Bristol-Myers Squibb Co. | TETRAHYDROISOCHINOLINE ANALOGUE AS GROWTH HORMONE SECRETAGOGA |
AU2001264977B2 (en) | 2000-05-30 | 2005-04-14 | Merck & Co., Inc. | Melanocortin receptor agonists |
CZ20024003A3 (en) | 2000-06-09 | 2003-03-12 | Aventis Pharma Deutschland Gmbh | Acylphenyl urea derivatives, process of their preparation and use as a medicament |
EP1182251A1 (en) * | 2000-08-11 | 2002-02-27 | Yissum Research Development Company of the Hebrew University of Jerusalem | Methods for identifying compounds that inhibit ubiquitin-mediated proteolysis of IkB |
TWI243162B (en) | 2000-11-10 | 2005-11-11 | Taisho Pharmaceutical Co Ltd | Cyanopyrrolidine derivatives |
KR100833089B1 (en) | 2000-12-21 | 2008-05-29 | 사노피-아벤티스 도이칠란트 게엠베하 | Novel 1,2-diphenylazetidinones and a pharmaceutical composition for treating disorders of the lipid metabolism comprising the same |
EP1726586A1 (en) * | 2000-12-25 | 2006-11-29 | Ono Pharmaceutical Co., Ltd. | Dihydronaphthalene derivative compounds and agent comprising the derivative as active ingredient |
PE20021091A1 (en) | 2001-05-25 | 2003-02-04 | Aventis Pharma Gmbh | DERIVATIVES OF PHENYLUREA SUBSTITUTED WITH CARBONAMIDE AND PROCEDURE FOR THEIR PREPARATION |
DE10154689A1 (en) | 2001-11-09 | 2003-05-22 | Probiodrug Ag | Substituted amino ketone compounds |
US6623261B2 (en) | 2001-07-21 | 2003-09-23 | Thomas C. Edwards | Single-degree-of-freedom controlled-clearance univane™ fluid-handling machine |
DE10142734A1 (en) * | 2001-08-31 | 2003-03-27 | Aventis Pharma Gmbh | New (((oxazolylalkyl)-cycloalkyl)-alkyl)-benzoic acid derivatives, are peroxisome proliferator activated receptor agonists or antagonists used e.g. for treating lipid metabolism disorders, type II diabetes, syndrome X and obesity |
ES2278077T3 (en) * | 2001-08-31 | 2007-08-01 | Sanofi-Aventis Deutschland Gmbh | DERIVATIVES OF DIARILCICLOALQUILO, PROCEDURE FOR ITS PREPARATION AND ITS USE AS PPAR ACTIVATORS. |
IL164249A0 (en) | 2002-04-11 | 2005-12-18 | Aventis Pharma Gmbh | Acyl-3-carboxphenylurea derivatives, processes forpreparing them and their use |
DE10215908B4 (en) | 2002-04-11 | 2005-08-18 | Aventis Pharma Deutschland Gmbh | Acyl-3-carboxyphenyl-urea derivatives and their use as medicaments |
DE10225635C1 (en) | 2002-06-07 | 2003-12-24 | Aventis Pharma Gmbh | N-benzoylureido-cinnamic acid derivatives, process for their preparation and their use |
DE10231370B4 (en) | 2002-07-11 | 2006-04-06 | Sanofi-Aventis Deutschland Gmbh | Thiophene glycoside derivatives, medicaments containing these compounds and methods of making these medicaments |
DE10258007B4 (en) | 2002-12-12 | 2006-02-09 | Sanofi-Aventis Deutschland Gmbh | Aromatic fluoroglycoside derivatives, medicaments containing these compounds and methods for the preparation of these medicaments |
DE10258008B4 (en) | 2002-12-12 | 2006-02-02 | Sanofi-Aventis Deutschland Gmbh | Heterocyclic fluoroglycoside derivatives, medicaments containing these compounds and methods of making these medicaments |
US7094795B2 (en) * | 2003-02-27 | 2006-08-22 | Sanofi-Aventis Deutschland Gmbh | Process for preparing the enantiomeric forms of cis-configured 1,3-cyclohexanediol derivatives |
US7148246B2 (en) * | 2003-02-27 | 2006-12-12 | Sanofi-Aventis Deutschland Gmbh | Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals |
DE10308355A1 (en) * | 2003-02-27 | 2004-12-23 | Aventis Pharma Deutschland Gmbh | Aryl-cycloalkyl-substituted alkanoic acid derivatives, process for their preparation and their use as medicaments |
DE10308351A1 (en) * | 2003-02-27 | 2004-11-25 | Aventis Pharma Deutschland Gmbh | 1,3-substituted cycloalkyl derivatives having acidic, usually heterocyclic groups, processes for their preparation and their use as medicaments |
-
2003
- 2003-02-27 DE DE10308353A patent/DE10308353A1/en not_active Withdrawn
-
2004
- 2004-02-19 WO PCT/EP2004/001584 patent/WO2004075815A2/en active Application Filing
- 2004-02-19 KR KR1020057016020A patent/KR20050106053A/en not_active Application Discontinuation
- 2004-02-19 PL PL377741A patent/PL377741A1/en not_active Application Discontinuation
- 2004-02-19 RU RU2005129999/04A patent/RU2005129999A/en not_active Application Discontinuation
- 2004-02-19 CN CNB2004800054472A patent/CN100439346C/en not_active Expired - Fee Related
- 2004-02-19 EP EP04712502A patent/EP1599454B1/en not_active Expired - Lifetime
- 2004-02-19 JP JP2006501890A patent/JP2006519197A/en active Pending
- 2004-02-19 MX MXPA05008993A patent/MXPA05008993A/en active IP Right Grant
- 2004-02-19 CA CA002516573A patent/CA2516573A1/en not_active Abandoned
- 2004-02-19 AU AU2004216520A patent/AU2004216520B2/en not_active Ceased
- 2004-02-19 BR BRPI0407901-9A patent/BRPI0407901A/en not_active IP Right Cessation
- 2004-02-25 TW TW093104700A patent/TW200505880A/en unknown
- 2004-02-27 US US10/789,019 patent/US7160911B2/en not_active Expired - Lifetime
- 2004-02-27 AR ARP040100633A patent/AR043430A1/en not_active Application Discontinuation
-
2005
- 2005-07-19 ZA ZA200505763A patent/ZA200505763B/en unknown
- 2005-08-16 IL IL170313A patent/IL170313A/en not_active IP Right Cessation
- 2005-08-26 CO CO05085505A patent/CO5690579A2/en not_active Application Discontinuation
- 2005-08-26 MA MA28464A patent/MA27741A1/en unknown
- 2005-08-26 HR HR20050740A patent/HRP20050740A2/en not_active Application Discontinuation
- 2005-09-21 NO NO20054382A patent/NO20054382L/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP1599454B1 (en) | 2012-12-26 |
EP1599454A2 (en) | 2005-11-30 |
WO2004075815A3 (en) | 2004-12-29 |
CA2516573A1 (en) | 2004-09-10 |
AU2004216520B2 (en) | 2010-01-07 |
PL377741A1 (en) | 2006-02-20 |
IL170313A (en) | 2010-11-30 |
AR043430A1 (en) | 2005-07-27 |
CO5690579A2 (en) | 2006-10-31 |
HRP20050740A2 (en) | 2006-08-31 |
DE10308353A1 (en) | 2004-12-02 |
US7160911B2 (en) | 2007-01-09 |
RU2005129999A (en) | 2006-03-27 |
NO20054382L (en) | 2005-09-21 |
JP2006519197A (en) | 2006-08-24 |
MA27741A1 (en) | 2006-02-01 |
TW200505880A (en) | 2005-02-16 |
MXPA05008993A (en) | 2005-10-18 |
ZA200505763B (en) | 2006-05-31 |
AU2004216520A1 (en) | 2004-09-10 |
KR20050106053A (en) | 2005-11-08 |
US20040204462A1 (en) | 2004-10-14 |
WO2004075815A2 (en) | 2004-09-10 |
CN100439346C (en) | 2008-12-03 |
CN1753880A (en) | 2006-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0407901A (en) | diarylcycloalkyl derivatives, processes for their preparation and use as medicines | |
BRPI0514310A (en) | Substituted 8-aminoalkoxy xanthines, method for their production and use as medicines | |
BR0210008A (en) | Carboxamide-substituted phenylurea derivatives, processes for producing them as medicaments | |
BRPI0510599A (en) | compounds, process for preparing same, pharmaceutical composition, use of a compound, and method for treating and prophylaxing diseases | |
BRPI0507309A (en) | 7-phenylamino-4quinolon-3-carboxylic acid derivatives, processes for production and their use as a medicine | |
BR0312697A (en) | Heterocyclically substituted benzoylureas, process for their preparation and application as a medicine | |
BRPI0606930A2 (en) | compound or a pharmaceutically acceptable salt thereof, process for preparing a compound or a pharmaceutically acceptable salt thereof, pharmaceutical composition, use of a compound or a pharmaceutically acceptable salt thereof, and methods for producing a drug inhibiting effect. b-raf in a warm-blooded animal, for producing an anti-cancer effect on a warm-blooded animal and for treating diseases of an animal in a warm-blooded animal | |
BRPI0512796A (en) | compound, process for preparing same, pharmaceutical composition, use of a compound, and methods for producing an inhibitory effect of b-raf, and an anticancer effect on a warm-blooded animal, and for treating a disease. | |
BRPI0910832B8 (en) | thienopyridone derivatives as amp-activated protein kinase (ampk) activators, their uses, their preparation process and their intermediates, and drugs. | |
BR0009641A (en) | 1,4-benzothiazepin-1,1-dioxide derivatives, substituted with sugar radicals, process for their production, drugs containing these compounds and their use | |
BR0212158A (en) | Diarylcycloalkyl derivatives, processes for their preparation and their application as ppar activators | |
BRPI0513086A (en) | Bicyclically substituted 8-pyrrolidinoxanthines, process for their production and use as medicines | |
BRPI0407907A (en) | aryl cycloalkyl substituted alkaline acid derivatives, processes for preparing them and using them as medicines | |
BR0014827A (en) | Tert-Butyl- (7-methyl-imidazo (1,2-a) pyridin-3-yl) amine derivatives, procedure for their preparation, medicines containing them, their use for the preparation of medicament for inhibiting no synthase and pharmaceutical compositions containing them | |
BRPI0512330A (en) | pyrazol pyrimidine derivatives | |
BRPI0410760A (en) | compounds, process for making same, pharmaceutical compositions and use of these compounds | |
BR122019010200B8 (en) | pyrazole-quinazoline compounds, their salts, products or kits and pharmaceutical compositions | |
BR0214986A (en) | S-enanciomer of a compound, compound, pharmaceutical formulation, method of treating or preventing lipid disorders, use of a compound, method of treating or preventing type 2 diabetes, process for preparing a compound, and, pharmaceutical composition | |
BRPI0515168A (en) | 7-azaindoles, processes for their preparation and their use as pharmaceuticals | |
BRPI0518898A2 (en) | compound, process for its preparation, pharmaceutical composition, method for treatment and use of the compound | |
BRPI0514035A (en) | compound, pharmaceutically acceptable salts thereof, diastereomers, enantiomers or mixtures thereof, use of a compound, pharmaceutical composition, method for the therapy of depression in a warm-blooded animal, and process for preparing a compound | |
BRPI0519280A2 (en) | compound, pharmaceutical composition and use of a compound | |
BR0114092A (en) | Substituted cinnamic acid guanidides, processes for their preparation, their application as a medicine and the medicine containing them | |
BR0311896A (en) | Acid-Substituted Diphenylazetidinones, Processes for Preparing them, Drugs Containing these Compounds and Their Use | |
BRPI0514014A (en) | compound, use thereof, pharmaceutical composition, methods for the treatment of pain, anxiety, and parkinson's disease in a warm-blooded animal, and process for the preparation of a compound |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B08F | Application fees: application dismissed [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 8A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2144 DE 07/02/2012. |